Introduction
============

In the last years were published numerous epidemiological studies that tried to link driving under the influence of cannabis (DUIC) with the risk of various unfavorable traffic events (UTEs) -- collision, injury, or death. Most of them had important limitations (see e.g., [@B15]; [@B27]; [@B2]). For example, some articles did not differentiate between testing for tetrahydrocannabinol (THC) and its core metabolite -- 11-Nor-9-carboxy-Δ^9^-tetrahydrocannabinol (THC-COOH) ([@B27]). THC-COOH is formed through the hepatic oxidation of the active metabolite, after which is conjugated with glucuronide ([@B47]), resulting in a water-soluble substance that can be easily excreted ([@B28]). Unlike THC, which has a half-life of about 7 h ([@B5]), THC-COOH can be detected in body fluids and may give a positive test for cannabis use for several days (or even weeks in heavy users), even though the active component is absent ([@B4]), leading to a false belief that the person is DUIC. Additionally, in the terminal elimination phase of the metabolite, a single subject may produce consecutive specimens that could be tested positive, negative, and again positive, making it very hard to differentiate a new episode of consumption from a previous cannabis exposure ([@B18]). There is always some delay between UTE and the moment of collecting biological samples, which makes the simple determination of the relationship between cannabis use and collision risk very difficult.

Many studies analyzed the association between cannabis use and UTEs through "self-reporting," a method known to underestimate the actual proportion of cannabis users ([@B15]; [@B2]), as many users tend not to report consumption of an illegal substance. Also, it is possible that a driver may have a positive result for cannabis, be involved in a car crash, but not be in an impaired driving status. Some studies evaluated the association between DUIC and UTE through epidemiological surveys, other used public datasets, culpability studies, or case--control studies. Some articles analyzed the association between previous use of cannabis and the risk of traffic events, showing an increased risk ([@B6]; [@B32]; [@B48]) while other reached inconclusive results ([@B15]; [@B2]).

Also, three recent meta-analyses tried to summarize the effect size of DUIC ([@B1]; [@B30]; [@B43]) and suggested that the risk of UTEs is increased by cannabis ([@B1]; [@B30]; [@B43]) used a random-effect model to assess the effect size of cannabis use on UTEs, but they failed to provide prediction intervals (PI) for their values. [@B43] used a meta-regression model for estimating the publication bias, which was one of the objectives of our study.

Aim
---

The primary objective of this study was to analyze whether there is a significant association between DUIC and UTEs.

Secondary objectives:

1.  To test whether DUIC is associated with an increased risk of unfavorable driving-related outcomes compared to chronic cannabis use, based on recent published literature (after 2000).

2.  To test whether publishing bias is significant in studies dealing with cannabis use in drivers.

3.  To see whether the self-reported use of cannabis during driving leads to an under-reporting of the actual cannabis use while driving.

Materials and Methods {#s1}
=====================

The study was performed by following PRISMA and MOOSE guidelines for reporting systematic reviews and meta-analyses of observational studies in epidemiology.

Selection Criteria
------------------

Inclusion criteria: (1) observational studies, with control or comparison group, published after 2000, in which cannabis usage was associated with UTEs. We used as exclusion criteria: (1) the absence of relevant information to reconstruct the data needed for the analysis, (2) case series and studies without a control group, (4) studies not published in English, and (5) studies not published as scientific articles. Cannabis use was assessed by detection of THC in blood, metabolites in urine or saliva, or through self-report of cannabis use previous to the car crash. Chronic cannabis use was assessed through self-reports. Chronicity was taken directly from the studies, and its assessment was, therefore, author-specific.

Search Method
-------------

We analyzed the results obtained from three databases: ISI Web of Science, Pubmed, and Scopus. For Pubmed, we used the following keywords: accidents, traffic \[MeSH Terms\] OR motor vehicle \[MeSH Terms\] OR collision \[MeSH Terms\] AND cannabi^∗^ OR marijuana \[MeSH Terms\] OR THC \[MeSH Terms\]. For Scopus and Web of Science, we used similar keywords, depending on the specifics of each database. We preferred not using additional restrictive criteria like article type because some other varieties (reviews, case presentations, letters to the editor) were considered as potentially adding relevant information to the meta-analysis (discussions, finding other relevant articles).

Data Collection and Analysis
----------------------------

For selected studies, two reviewers extracted the data separately and included it in Excel datasheets. We summarized the following information: study, year, the total number of cases, country, type of study, type of consumption (acute/chronic), methods of detecting cannabis use, interferences with drinking alcoholic beverages, outcome, mean age and sex ratio for each group, and statistical data. We used the following types of information (in the preferred order): case--control 2 × 2 data, OR and CI, OR (ln(OR)) and SE, or RR. We transformed RR to OR by using the following formula: OR = RR(1-*p*)/(1-*p*RR), where *p* was the prevalence of cannabis use in that country, taken from the EMCDDA datasheets for Europe or CAS/CADUMS database for Canada. The agreement rate between researchers was 94%. Where we found discrepancies, the issues were analyzed by a third reviewer.

The Risk of Bias
----------------

The risk of bias was assessed separately for each case, at a study level, and it was included in the quality assessment. We included selection bias, multiple publication biases (reason for removing two articles from the meta-analysis), and sampling bias.

The Quality Assessment
----------------------

The quality assessment included the examination of the ensuing data: (1) number of cases (including the ratio cases/controls); (2) the type of study; (3) usefulness of data (a good identification of adjusted, and non-adjusted odds ratios (ORs), clear differentiation between DUIC and previous cannabis use, differentiation of cannabis usage alone from cannabis with other drugs, blood sampling versus self-reports); (4) recruitment strategy; (5) a clear differentiation between cannabis and alcohol use in the study; (6) methods of detecting cannabis; (7) external validity; and (8) a proper assessment of the limits of the study.

Based on the elements mentioned above, we drafted a 21 points scale that we used to separate the studies into high-quality, medium-quality, and low-quality. We obtained the score for each study by dividing the obtained value by 21. We then considered as (1) high-quality studies those whose score was above mean + standard deviation; (2) medium-quality those whose score was between mean - standard deviation and mean + standard deviation; (3) low-quality those whose score was below mean - standard deviation. The scale was computed separately by two researchers. The agreement rate between researchers was 89%. All differences in evaluating the quality of a study were analyzed by a third reviewer.

Statistical Analysis
--------------------

We determined the effect size in all cases using a random-effects model computed in Microsoft Excel 2013 with MetaXL package and verified by using CMA v2 software. For each group and subgroup, we performed a forest plot. For the analysis of publication bias, depending on the type of sub-analysis, we used the following: funnel plot, Rosenthal's fail-safe N, and Duval and Tweedy's Trim and Fill technique. For comparison of the effect size between two groups, we used the *Z*-test method. PI and the comparison of the effect size between groups were performed by using Microsoft Excel 2013. We also computed the effect size using a novel method that was developed specifically to reduce heterogeneity and aimed to replace the random-effects model, namely the inverse variance heterogeneity (IVhet). The model was constructed using Microsoft Excel 2013 with MetaXL package. We used 95% confidence and PIs; we considered a *p*-value \<0.05 to be statistically significant; and an effect size to be small at OR values of around 1.44, medium at OR values around 2.47, and large at OR values around 4.25.

Results
=======

Search Synthesis
----------------

We obtained 1878 results from which, after deleting duplicate and irrelevant studies, and analyzing the type of paper and abstracts (if available), we selected 57 articles. They were downloaded and analyzed further. Scrutinizing the references of these 57 articles, we identified three more relevant papers. From the total number of 60 articles, we selected 24 for the current study, which completely respected the inclusion criteria and were encompassed in the meta-analysis. Details are presented in **Figure [1](#F1){ref-type="fig"}**. We only selected studies published as scientific articles, as one of the objectives of this study was to assess publication bias. We detailed the papers included in the analysis in **Table [1](#T1){ref-type="table"}**. If two articles contained overlapping data, the newest article was removed from the analysis.

![Search synthesis.](fphar-09-00099-g001){#F1}

###### 

Synthesis of the studies included in the meta-analysis.

  Reference   Year   Geographical area                                          Sample size              Study design           Cases                                                                                            Outcome        Type of data          Detection details
  ----------- ------ ---------------------------------------------------------- ------------------------ ---------------------- ------------------------------------------------------------------------------------------------ -------------- --------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B2]       2014   Canada                                                     860                      Case control           Drivers involved in collisions                                                                   Injury         Blood, self-report    Active THC metabolite was measured in blood if the driver came to the emergency department within 6 h of the collision. The limit of detection was 0.2 ng/ml. Confounders: alcohol concentration, benzodiazepines, and cocaine. Self-report analyzed usual patterns of substance use over the past 6 months, including harmful use measured through the Alcohol Use Disorders Identification Test (AUDIT) and the Cannabis Use Disorders Identification Test (CUDIT)
                                                                                                                                                                                                                                                                      
  [@B3]       2005   Canada                                                     6033 (3,191/1,964/878)   Survey                 Driving within 1 h after using marijuana or chronic marijuana use                                Collision      Self-report           Self-reported questionnaire containing 100 items requesting information about demographics, social environment, substance use, gambling, school rules, mental health, and help-seeking
                                                                                                                                                                                                                                                                      
  [@B5]       2007   Canada                                                     32,543                   Case control           Drivers, with at least one potentially unsafe driving action recorded in relation to the crash   Death          Official databases    Interrogation of the FARS database (1993--2003), for drivers who had at least one potentially unsafe driving action recorder in relation to the crash versus subjects without such driving actions, who had been tested for cannabis and had a alcohol concentration of 0
                                                                                                                                                                                                                                                                      
  [@B6]       2005   New Zeeland                                                1,159 (552/587)          Case control           Drivers, involved in crashes, driving within 3 h after using marijuana                           Injury/death   Self-report           Telephone administered questionnaire. Case vehicles were defined as all cars involved in crashes where at least one person was hospitalized with injuries, or killed. Controls were selected through random cluster sampling. The medical records of the cases were examined, and relevant information (such as BAC) were obtained. Marijuana use was determined through two questions: usage of marijuana in the 3 h prior to the crash; for habitual use -- the subjects were asked about the frequency of marijuana use in the last 12 months
                                                                                                                                                                                                                                                                      
  [@B8]       2003   Canada                                                     758                      Case control           Drivers with a history of cannabis use                                                           Collisions     Self-report           Self-report
                                                                                                                                                                                                                                                                      
  [@B9]       2011   Brazil                                                     609                      Cross-sectional        Drivers, various groups                                                                          Injury         Self-report, saliva   Self-report. Screening of marijuana use on saliva tests analyzed through an ELISA assay, with a cut-off of 4 ng/ml THC
                                                                                                                                                                                                                                                                      
  [@B13]      2008   New Zeeland                                                936                      Retrospective cohort   Drivers, cannabis users                                                                          Collision      Self-report           Self-report, during the Christchurch Health and Development Study
                                                                                                                                                                                                                                                                      
  [@B16]      2011   Norway                                                     10,744 (204/10,540)      Case control           Drivers, fatally injured                                                                         Death          Blood                 Data on blood samples submitted for forensic toxicological analysis of alcohol or drugs at the Norwegian Institute of Public Health (NIPH). Cases were excluded if the time lapse between accident and death was more than 1 day. Drug findings were confirmed and quantified using gas chromatography with mass spectroscopy detection (GC--MS) or LC--MS. The cut-off values for THC was 0.6 ng/ml in blood
                                                                                                                                                                                                                                                                      
  [@B23]      2013   Belgium, Finland, Denmark, Italy, Lithuania, Netherlands   18,322                   Case control           Severely injured drivers                                                                         Injury         Saliva/blood          Oral fluid and/or blood samples were collected at the road side (controls) and blood was sampled in the hospitals (cases), using country-dependent methods
                                                                                                                                                                                                                                                                      
  [@B26]      2012   Belgium                                                    3095 (337/2758)          Case control           Hospitalized drivers                                                                             Injury         Blood                 Blood analyses performed by validated GC--MS. Cut-off for THC -- 1 ng/ml
                                                                                                                                                                                                                                                                      
  [@B27]      2005   France                                                     9772 (6766/3006)         Case control           Fatally injured drivers                                                                          Death          Blood                 Blood analyses performed by GC--MS. Cut-off for THC -- 1 ng/ml
                                                                                                                                                                                                                                                                      
  [@B29]      2013   United States                                              8456 (737/7719)          Case control           Fatally injured drivers                                                                          Death          Blood/urine/saliva    Drug tests for cases were performed using blood and/or urine specimens through liquid/gas chromatography, mass spectrometry, and radioimmunoassay technique. For controls were used oral liquid samples, which were first screened for drugs through the enzyme-linked immunosorbent assay and then analyzed for confirmation through chromatography and spectrometry techniques
                                                                                                                                                                                                                                                                      
  [@B31]      2000   Australia                                                  1975 (1038/937)          Case control           Culpable drivers                                                                                 Injury         Blood                 Blood samples tested for THC and THC-COOH. THC concentration was divided into drug free, 1 ng or less, 1.1--2 ng, and 2.1 or more ng/ml
                                                                                                                                                                                                                                                                      
  [@B32]      2007   Canada                                                     2676                     Survey                 Cannabis users, driving within 1 h after using marijuana                                         Collision      Self-report           Self-reported, through telephone-based questionnaires
                                                                                                                                                                                                                                                                      
  [@B33]      2012   Pakistan                                                   857                      Survey                 Drivers, consuming cannabis                                                                      Collision      Self-report           Self-reported through interview-based questionnaires
                                                                                                                                                                                                                                                                      
  [@B34]      2004   Netherlands                                                926 (110/816)            Case--control          Injured drivers                                                                                  injury         Urine/blood           Urine samples were screened with an enzyme multiplied immunoassay technique and confirmed with GC--MS. Drug screening in serum was done with enzyme immunoassay and confirmation was done with GC--MS
                                                                                                                                                                                                                                                                      
  [@B36]      2003   France                                                     1800 (900/900)           Case--control          Injured drivers                                                                                  Injury         Blood                 Blood samples, taken with an average time of 1.8 ± 0.9 h after a car crash. Subjects were screened for THC, 11-OH-THC, and THC-COOH with GC--MS/HPLC, cut-off for THC: 1 ng/ml
                                                                                                                                                                                                                                                                      
  [@B40]      2011   Spain                                                      503                      Case--control          Regular cocaine users recruited from non-treatment centers                                       Injury         Self-report           Self-reported usage, 60 and 120 min prior to a car crash
                                                                                                                                                                                                                                                                      
  [@B44]      2014   United States                                              5190 (1766/3424)         Case--control          Injured drivers                                                                                  Injury         Official databases    FARS database, 2007--2008
                                                                                                                                                                                                                                                                      
  [@B48]      2014   United States                                              72,053                   Retrospective cohort   Cannabis users                                                                                   Collision      Self-report           Questions about self-use of marijuana in the last 12 months
                                                                                                                                                                                                                                                                      
  [@B52]      2009   Thailand                                                   1049 (200/849)           Case--control          Injured drivers                                                                                  Injury         Urine                 Urine samples, tested through GC--MS, cut-off 50 ng/ml
                                                                                                                                                                                                                                                                      
  [@B15]      2003   United States                                              64,657 (188/64469)       Retrospective cohort   Members of a medical insurance program aged 15--49 years, variable patterns of marijuana use     Collision      Self-report           Self-report of marijuana use, as classified in never use, experimental use, former use, and current use
                                                                                                                                                                                                                                                                      
  [@B17]      2009   Switzerland                                                486                      Case--control          Injured drivers                                                                                  Injury         Self-report, blood    Self-reported use, 6 h before a car crash. Subjects were screened for THC, 11-OH-THC, and THC-COOH. Cut-off for THC: 0.5 ng/ml
                                                                                                                                                                                                                                                                      
  [@B24]      2005   Australia                                                  320                      Retrospective cohort   Cannabis users involved in crashes, dependent                                                    Collision      Self-report           Self-reported use of cannabis
                                                                                                                                                                                                                                                                      

Quality Assessment
------------------

The final mean score was 0.62 and the standard deviation was 0.19. The distribution of the quality scores is shown in **Figure [2](#F2){ref-type="fig"}**.
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Driving under the Influence of Cannabis Unadjusted
--------------------------------------------------

Twenty-three studies contained unadjusted data about DUIC (**Figure [3](#F3){ref-type="fig"}**). The effect size was mild, with OR = 1.889, CI = (1.580--2.258) and a PI between 0.92 and 3.84, not statistically significant (PI overlapped the value 1).

![Forrest plot. Studies grouped by outcome (RE Model).](fphar-09-00099-g003){#F3}

By analyzing the funnel plot (**Figure [4](#F4){ref-type="fig"}**) of this distribution, we saw an increased asymmetry number of cases outside the funnel, implying a potential publication bias. The Rosenthal fail-safe N gave a *Z*-value of 19.01 (*p* \< 0.001), being needed 2143 missing studies to bring the *p*-value over alpha (1.96). The Duval and Tweedie's Trim and Fill method adjusted the OR to 1.21 (1.01--1.44). The effect size, as computed using the IVhet method, was 1.12 (0.59--2.12).

![Funnel plot -- unadjusted.](fphar-09-00099-g004){#F4}

Driving under the Influence of Cannabis--Blood Analysis
-------------------------------------------------------

Ten studies included data that allowed us to reconstruct a proper methodological blood analysis of the samples taken from drivers ([@B31]; [@B34]; [@B27]; [@B35]; [@B17]; [@B16]; [@B26]; [@B23]; [@B29]; [@B2]). By including them in the analysis, we found a modest increase in the OR to 1.97, CI D (1.35--2.87), with a PI of 0.59--6.49 (**Figure [5](#F5){ref-type="fig"}**). The effect size difference between the values obtained for "DUIC-unadjusted" and "DUIC--blood analysis" was not statistically significant (*Z*~diff~ = -0.19, *p* = 0.84). The Rosenthal fail-safe N had a *Z*-score of 3.18 (*p* \< 0.001), suggesting that there should be added 171 missing studies to bring the *p*-value over alpha (1.96). The Duval and Tweedie's Trim and Fill method did not adjust the OR (no studies were trimmed). The effect size, as computed using the IVhet method, was 2.01 (1.23--3.29).

![Forrest plot. Studies that estimated DUIC through blood analysis (RE Model).](fphar-09-00099-g005){#F5}

Chronic Cannabis Use
--------------------

Five studies had data about the effect of chronic marijuana use in relation with UTEs (see **Figure [6](#F6){ref-type="fig"}** for details). By including them in the analysis, we found an OR value that was similar to the one associated with DUIC 1.75, a CI between 1.21 and 2.53, and a PI between 0.46 and 6.6. The effect size difference between the values obtained for DUIC and chronic use was not significant (*Z*~diff~ = -0.36, *p* = 0.71). Similarly, the effect size difference between the values obtained for DUIC--blood analysis and chronic cannabis use was not statistically significant (*Z*~diff~ = -0.99, *p* = 0.32). The Duval and Tweedie's Trim and Fill method decreased the OR to 1.02 (0.71--1.47). The effect size, as computed using the IVhet method, was 1.02 (0.49--2.11).

![Forrest plot. Studies that estimated chronic cannabis use in drivers (RE Model).](fphar-09-00099-g006){#F6}

DUIC through Self-Reports
-------------------------

Eight studies included information about the effect size of DUIC, as presented through self-reports and UTEs (see **Figure [7](#F7){ref-type="fig"}** for details). By including them in the analysis, we obtained an OR of 1.94 (1.26--2.99) and a PI between 0.45 and 8.34. The effect size difference between DUIC--blood analyses and DUIC through self-reports was not statistically significant (*Z*~diff~ = -0.05, *p* = 0.95). The Rosenthal fail-safe N had a *Z*-score of 15.87 (*p* \< 0.001), suggesting that there should be added 518 missing studies to bring the *p*-value over alpha (1.96). The Duval and Tweedie's Trim and Fill method decreased the OR to 1.22 (0.81--1.82). The effect size, as computed using the IVhet method, was 1.12 (0.38--3.30).

![Forrest plot. Studies that estimated DUIC through self-reports (RE Model).](fphar-09-00099-g007){#F7}

DUIC with THC Blood Levels Over 0.5 ng/ml
-----------------------------------------

Three studies contained data about the effect size of DUIC with THC blood levels above 0.5 ng/ml on UTEs ([@B27]; [@B17]; [@B26]). By including them in the analysis, we obtained an OR of 2.085 (0.35--12.43) and a PI between 0.0000001 and 6107085547. The effect size, as computed using the IVhet method, was 2.28 (0.22--23.82).

Effect Size of the DUIC Depending on the Outcome
------------------------------------------------

The forest plot of the subgroup analysis is presented in **Figure [3](#F3){ref-type="fig"}**. A comparison of the other statistical parameters is presented in **Table [2](#T2){ref-type="table"}**. For collision or injury as outcomes, the effect was not statistically significant. For death, the effect size was statistically significant using the IVhet method (1.56, CI = 1.16--2.09).

###### 

Effect sizes depending on the outcome (italics -- statistically significant increase in the effect size).

  Outcome     Random-effect model   Trim and Fill   IVhet                                           
  ----------- --------------------- --------------- ------------ -------- ---------------- -------- ----------------
  Collision   1.95                  1.24--3.05      0.41--9.20   1.22     0.82--1.81       1.12     0.41--3.03
  Injury      2.16                  1.41--3.28      0.50--9.3    1.47     0.94--2.29       1.54     0.66--3.59
  Death       1.73                  1.36--2.19      0.77--3.84   *1.43*   *1.12*--*1.83*   *1.56*   *1.16*--*2.09*
                                                                                                    

Effect Size of the DUIC Based on the Type of Study
--------------------------------------------------

The comparison of effect size based on the type of study is presented in **Table [3](#T3){ref-type="table"}**. We assessed retrospective, cross-survey, and survey studies together due to their low number. Neither had statistically significant effect sizes as obtained using the random-effects model separately. From **Table [3](#T3){ref-type="table"}** we see that case--control studies have a significantly increased effect size using IVHet (IVHet = 1.99, CI = 1.05--3.80).

###### 

Effect sizes depending on the type of study (italics -- statistically significant increase in the effect size).

  Type of study   Random-effect model   Trim and Fill   IVhet                                         
  --------------- --------------------- --------------- ------------ -------- -------------- -------- --------------
  Case--control   1.951                 1.51--2.51      0.82--4.63   *1.58*   *1.20--2.07*   *1.99*   *1.05--3.80*
  Other types     1.81                  1.38--2.39      0.78--4.21   1.16     0.91--1.51     1.13     0.39--3.27
                                                                                                      

Effect Size Considering Adjustments Made by Authors to the OR
-------------------------------------------------------------

In 12 studies, the authors adjusted the OR value for various confounding variables (see **Figure [8](#F8){ref-type="fig"}** for details). By including them in the analysis, we found an OR value of 1.42 with a CI between 1.19 and 1.71 and a PI between 0.85 and 3.6. The Duval and Tweedie's Trim and Fill method decreased the OR to 1.19 (0.99--1.42). The effect size, as computed using the IVHet method, was 1.09 (0.73--1.62).

![Forrest plot. Studies in which the authors provided additional adjustments to the model (RE Model).](fphar-09-00099-g008){#F8}

Discussion
==========

The association between DUIC and the risk of road traffic events was intensely studied before ([@B51]; [@B41]; [@B35]; [@B49]; [@B45]; [@B38]; [@B39]; [@B29]; [@B46]; [@B48]; [@B50]). There are several methods of assessing this association -- from experimental studies aimed to measure the influence of THC on driving performance, to epidemiological, culpability, or case--control studies. Although each add pieces of information, a definite answer is difficult to obtain, as these studies often had conflicting results and the research methodology was regularly prone to biases. Due to these reasons, a series of systematic reviews (e.g., [@B41]) or meta-analysis ([@B1]; [@B30]) were recently published, which strongly suggested an association between DUIC and UTEs.

When reporting a meta-analysis carried out using the random-effects model, the researchers usually present the summary effect size and its CI. These values allow us to estimate the mean effect size and precision but not the distribution of the true effects around the summary effect ([@B7]). Therefore, when exhibiting the result of a random-effect meta-analysis, we should detail three pieces of information: mean effect size, CI, and PI. The PI shows the distribution of the true effect sizes around the mean. Both meta-analyses ([@B1]; [@B30]), as discussed above, used a random-effect model and obtained significant effect sizes. However, neither reported PIs for their analyses. By including the PI in the description of the results, we failed to obtain a significant association between DUIC or other computed parameters and UTEs, even if the OR and CI of our study were highly similar to theirs. Moreover, when analyzing various subgroups, we could not find statistical associations.

We could imagine three possible causes for the results obtained in our study: (1) the absence of any correlation between DUIC and UTEs; (2) a very high heterogeneity of the studies included in the analysis, which led to a very high dispersion of the true effect size; and (3) a lack of sensitivity of the random-effects model for our analysis. [@B42] argued that using PIs is appropriate when the studies included in the meta-analysis have a low risk of bias, which was not the case in our study (see *I*^2^ values in **Figures [3](#F3){ref-type="fig"}**, **[5](#F5){ref-type="fig"}**--**[8](#F8){ref-type="fig"}**).

The heterogeneity of the results is caused both by the different methodologies used by various studies and by the technical difficulties in actually assessing impairment of driving associated with cannabis use ([@B14]; [@B19]; [@B22]). For example, it is known that the concentration in blood of THC decreases rapidly after use, but the clinical effects take longer to dissipate ([@B20]). This, associated with the fact that sampling is done sometimes even hours after the event, may significantly alter the results. The metabolism of cannabinoids is highly variable in different subjects; therefore, at the same concentration, a person may be under the influence, while another may have normal driving ability ([@B20]). There is no standardized cut-off for blood THC from which a person is considered under the influence. For more details, see [@B37], Chapter 15).

To clarify which hypothesis is more plausible, we reanalyzed the studies, by using a newly developed approach to meta-analyses namely the IVHet model, which was developed specifically to decrease heterogeneity and increase the overall performance of the meta-analysis. Succinctly, IVHet has as key benefits over the random-effect model the lack of penalization for larger trials, a more conservative CI, and the fact that it exhibits a lesser true variance irrespective of the degree of heterogeneity ([@B10]). By using this approach, we identified a lack of significance when including in the final analysis studies that couldn't quantify the actual DUIC using objective methods (blood tests). When DUIC was properly established using blood tests, we saw an OR suggesting a small-to-medium effect size (by also considering the CI). Case--control studies showed a significantly increased effect size; most likely the primary cause is a more frequent usage of a blood test to detect THC compared to other study designs. Also, case--control tests may misrepresent the actual situation in the population from which the cases/controls were obtained, by inadvertently pre-selecting subgroups from the population of drivers, which are more prone to risky behaviors. For example, it is possible that the control group was matched for age and sex with the case group ([@B36]), not taking into account the fact that men and younger persons tend to use cannabis more frequently. Alternatively, it is possible that the design included temporal patterns of obtaining controls ([@B2]), not considering that cannabis use occurs more at night or weekends ([@B27]; [@B26]), when the risk of UTE is higher. Alternatively, the controls were matched geographically ([@B52]), not taking into account that usually urban areas have a higher overall usage of cannabis compared to the countryside ([@B12]; [@B30]), and subsequently there are differences in the collision risk ([@B25]; [@B53]). Some studies specifically scrutinized for this issue and adjusted the OR for confounding variables; by using this approach, they obtained inconclusive results even if they initially hinted an increased risk for cannabis users. For example, [@B6] showed a decrease in OR from 11.4 (3.63--35.75) to 0.8 (0.2--3.1) after adjusting for confounders. By using adjusted ORs in a separate inquiry, we obtained results that were highly similar with those obtained through the analysis of unadjusted ORs.

A similar reasoning could be applied to the association between cannabis use and death. All studies that included death as the outcome were case--controls. Moreover, for the cases group, intoxication status was assessed using blood analysis; the cannabis use in control subjects was evaluated using various methods including saliva and/or urine ([@B29]). Case--control studies in this field are known to have a high selection bias, caused by the fact that the two groups may be from different time periods or geographical regions, or they might include different cannabis-detection cutoffs ([@B21]).

Studies performed using other designs like retrospective cohorts or surveys often suffer from the same methodological flaws, especially preselecting participants who are more likely to use marijuana. They also rely heavily on self-reported cannabis use, that is known to under-represent the actual consumption and subsequently DUIC ([@B2]). Therefore, a methodology combining both types of studies would most likely obtain results that could reveal closer estimates of the true effect size of DUIC on UTEs.

We assessed publication bias both qualitatively (funnel plot) and quantitatively (Rosenthal's Fail-Safe N and Duval and Tweety's Trim and Fill methods). The latter were particularly useful as they allowed us to estimate the effect size after adjusting for publication bias. By analyzing the results obtained through the Trim and Fill method applied to the results of the random-effect model, we saw a sharp decrease in the effect size in most instances (except chronic cannabis use, that was usually used as a comparison/control group to acute exposure in the analyzed studies). Moreover, the results were, in most part, very close to those obtained using IVHet, suggesting that a significant proportion of the heterogeneity encountered by the random-effect model was caused by publication bias favoring studies that showed a positive association between DUIC and UTEs \[see [@B11] for further details\].

Our analysis suggested that the effect size for unadjusted DUIC on UTEs was not statistically significant. This result might be caused by (1) methodological flaws, which are often encountered in articles on this topic \[for a detailed analysis see [@B21]\]; (2) the indiscriminate use of the term cannabis use (which in our study included a wide array of studies, including some in which the cut-off value for this substance was below the one known to cause a significant clinical impairment); and (3) or a true absence of a negative effect of DUIC on UTEs. Simply identifying cannabis use in a driver is not enough to justify the assumption of an increased risk for UTEs. When such a result is obtained, it should be corroborated with either quantitative data regarding cannabis use, or a clinical assessment of the driver, before establishing his fitness to drive.

Limitations
===========

Many limitations were already presented in the section "Discussion," as they were intrinsically linked with the discussion of the results. Additionally, there were a few other limitation, that will be presented here. Most studies included in the meta-analysis failed to provide detailed descriptive data. For example, many didn't present mean age for the case and control groups, making it impossible to perform a meta-regression, needed to test the degree heterogeneity explained the age of the participants. Given that there are different types of outcomes (injury, death, collision), the obtained data from the pooled studies might be inconsistent -- for example, some of the injury reports have long delays from the crash to sampling limiting the detectability of THC in blood. We used a 0.5-ng/ml value as a cut-off for some analyses as this value was identified in a large enough number of articles, although a higher limit (2 or even 5 ng/ml) might have been more appropriate to test severe impairment due to marijuana abuse. A positive test for cannabis (i.e., blood) does not necessarily imply that drivers were impaired, as THC/metabolites might be detected in blood a long time after impairment, especially in chronic cannabis users, which could also induce an important bias in the analysis of the results. The unreliability of the self-reported studies cannot be properly tested. The literature of cannabis and its effects on driving ability is extremely difficult to analyze due to confounding generated by the measuring and interpreting THC, not only experimenter bias.

Conclusion
==========

Our analysis suggests that the overall effect size for DUIC on UTEs is not statistically significant, but there are significant differences obtained through subgroup analysis. This result might be caused by either methodological flaws (which are often encountered in articles on this topic), the indiscriminate employment of the term "cannabis use," or an actual absence of an adverse effect. When a driver is found, in traffic, with a positive reaction suggesting cannabis use, the result should be corroborated by either objective data regarding marijuana usage (like blood analyses, with clear cut-off values), or a clinical assessment of the impairment, before establishing his/her fitness to drive.
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